| Michael P Schulte, MD | |
|
119 Fairfield Ave, Suite R102, Bellevue, KY 41073-1184 | |
| (859) 431-0090 | |
| (859) 431-3168 |
| Full Name | Michael P Schulte |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 43 Years |
| Location | 119 Fairfield Ave, Bellevue, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043247141 | NPI | - | NPPES |
| 64222276 | Medicaid | KY | |
| 0101259 | Medicaid | OH | |
| 080092527 | Other | KY | RAILROAD MEDICARE |
| P00839891 | Other | KY | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 22227 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Elizabeth Edgewood | Edgewood, KY | Hospital |
| St Elizabeth Ft Thomas | Fort thomas, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group, Inc | 2163326240 | 693 |
News Archive
A web-based calculator that helps middle-aged women predict their risks of conditions that become more likely with age has been developed by public health, medical and computer science experts from throughout the U.S. and Saudi Arabia.
The recent report by the U.S. Centers for Disease Control and Prevention (CDC) published in JAMA Pediatrics, highlights the rising prevalence of prediabetes, which can lead to type 2 diabetes if it's not treated or controlled early. In the country, an estimated 18 percent among adolescents between the ages of 12 and 18, and 24 percent among young adults, between 19 and 34 have prediabetes.
Using a circular polymerase chain reaction, researchers have developed a method for making severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant virus, with the ability to introduce mutations. The research by Japanese scientists is published on the preprint server bioRxiv* in September 2020.
Aptuit announces the completion of the sale of the Clinical Trials Supply business to Catalent Pharma Solutions on February 17, 2012. Timothy C. Tyson, Chairman and CEO of Aptuit, LLC stated that Aptuit will continue to deliver scientific and service excellence to provide integrated capabilities for the early to mid phase drug development markets.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
› Verified 7 days ago
| Entity Name | Summit Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026169 PECOS PAC ID: 2163326240 Enrollment ID: O20031120000738 |
News Archive
A web-based calculator that helps middle-aged women predict their risks of conditions that become more likely with age has been developed by public health, medical and computer science experts from throughout the U.S. and Saudi Arabia.
The recent report by the U.S. Centers for Disease Control and Prevention (CDC) published in JAMA Pediatrics, highlights the rising prevalence of prediabetes, which can lead to type 2 diabetes if it's not treated or controlled early. In the country, an estimated 18 percent among adolescents between the ages of 12 and 18, and 24 percent among young adults, between 19 and 34 have prediabetes.
Using a circular polymerase chain reaction, researchers have developed a method for making severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant virus, with the ability to introduce mutations. The research by Japanese scientists is published on the preprint server bioRxiv* in September 2020.
Aptuit announces the completion of the sale of the Clinical Trials Supply business to Catalent Pharma Solutions on February 17, 2012. Timothy C. Tyson, Chairman and CEO of Aptuit, LLC stated that Aptuit will continue to deliver scientific and service excellence to provide integrated capabilities for the early to mid phase drug development markets.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael P Schulte, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (859) 431-0090 | Michael P Schulte, MD 119 Fairfield Ave, Suite R102, Bellevue, KY 41073-1184 Ph: (859) 431-0090 |
News Archive
A web-based calculator that helps middle-aged women predict their risks of conditions that become more likely with age has been developed by public health, medical and computer science experts from throughout the U.S. and Saudi Arabia.
The recent report by the U.S. Centers for Disease Control and Prevention (CDC) published in JAMA Pediatrics, highlights the rising prevalence of prediabetes, which can lead to type 2 diabetes if it's not treated or controlled early. In the country, an estimated 18 percent among adolescents between the ages of 12 and 18, and 24 percent among young adults, between 19 and 34 have prediabetes.
Using a circular polymerase chain reaction, researchers have developed a method for making severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant virus, with the ability to introduce mutations. The research by Japanese scientists is published on the preprint server bioRxiv* in September 2020.
Aptuit announces the completion of the sale of the Clinical Trials Supply business to Catalent Pharma Solutions on February 17, 2012. Timothy C. Tyson, Chairman and CEO of Aptuit, LLC stated that Aptuit will continue to deliver scientific and service excellence to provide integrated capabilities for the early to mid phase drug development markets.
Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for which there is currently no cure.
› Verified 7 days ago
Debra Schulte, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Casie Wiley, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1119 Fairfield Avenue, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Amanda M Evans, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 119 Fairfield Ave, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Jennifer Amy Adams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
William R Hammons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 | |
Jeremy D Engel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Fairfield Ave, Suite R102, Bellevue, KY 41073 Phone: 859-431-0090 Fax: 859-431-3168 |